Galera Therapeutics's total assets for Q3 2024 were $8.90M, a decrease of -45.67% from the previous quarter. GRTX total liabilities were $151.96M for the fiscal quarter, a -1.59% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.